These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9772523)

  • 1. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
    Chen M; Yu W; Hu S
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
    Pan CY; Lu JM; Chang XM; Luo GC; Li H
    Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
    Blickle JF; Schlienger JL; de Laharpe F; Stephan F
    Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GH, prolactin and microangiopathy in insulin-dependent diabetes].
    Cerutti F; Pagliero R; Ramenghi U; Sacchetti C; Baratono S; Altare F
    Minerva Pediatr; 1981 Feb; 33(3):127-30. PubMed ID: 7242486
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin C metabolites and microangiopathy in diabetes mellitus.
    Jennings PE; Chirico S; Jones AF; Lunec J; Barnett AH
    Diabetes Res; 1987 Nov; 6(3):151-4. PubMed ID: 3436115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the level of plasma D-dimer and diabetic microangiopathy].
    Long ZF; Qu GY; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):434-6. PubMed ID: 12536492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of growth hormone in the development of complications in insulin-dependent diabetes].
    Krawczuk-Rybak M; Urban M
    Padiatr Grenzgeb; 1991; 30(3):237-43. PubMed ID: 2067873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes.
    Lawecki J; Symonides-Lawecka A; Rogala H
    Pol Med Sci Hist Bull (1973); 1976; 15(2):177-82. PubMed ID: 959042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus.
    Aughsteen AA; Abu-Umair MS; Mahmoud SA
    Saudi Med J; 2005 Jan; 26(1):73-7. PubMed ID: 15756357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catecholamine excretion in diabetics on insulin treatment].
    Koev D; Ovcharova N; Kamenova P; Iankova G; Lefterova P
    Vutr Boles; 1990; 29(4):34-40. PubMed ID: 2281657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular alterations and GH secretion in latent chemical diabetes].
    Sgambato S; Carbone L; Bisesti V; Passariello N; Tesauro P; Varano R
    Boll Soc Ital Biol Sper; 1979 Feb; 55(3):279-85. PubMed ID: 399851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
    Sieradzki J
    Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy.
    Sampathkumar R; Balasubramanyam M; Sudarslal S; Rema M; Mohan V; Balaram P
    Clin Biochem; 2005 Oct; 38(10):892-9. PubMed ID: 16051210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of diabetic microangiopathy and diabetic control. A study in non-insulin-dependent diabetics.
    Maneschi F; Cassar J; Lowy C; Kohner EM
    Diabete Metab; 1981 Sep; 7(3):181-7. PubMed ID: 7033009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.